Found 12 matching trials
Danish Multicenter Scapholunate Ligament Study
NAComparison of two surgical techniques commonly used for reconstruction of t...
Location
Aarhus University Hospital
Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders
NAComorbid insomnia represents a frequent health problem in patients with sev...
Location
University Hospital of Psychiatry and Psychotherapy
Cardiopulmonary Changes Following Spinal Cord Stimulation in Individuals With Spinal Cord Injury
NAThe aim of this study is to examine the mechanisms of transcutaneous spinal...
Location
Blusson Spinal Cord Centre
Tight-Rope Augmented Adams Berger Technique for Distal Radioulnar Joint Instability
NABrief Summary This clinical study evaluated a new surgical technique for tr...
Location
Cemil Tascioglu Training and Research Hospital
Intraoperative Berger Space Imaging (IBSI)
NAThe investigational device is an approved femtosecond laser (FSL) device wi...
Location
Medical University of Vienna
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
PHASE1The goal of this clinical study is to evaluate multiple dose levels of pove...
Status
Active Not Recruiting
Location
Investigational Site (523)
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
PHASE2The purpose of this study is to collect long-term safety and tolerability d...
Status
Enrolling By Invitation
Location
Vera Therapeutics
Efficacy and Safety of Atacicept in IgA Nephropathy
PHASE2This main purpose of this study was to evaluate the safety, tolerability, d...
Location
AKDHC Medical Research Services, LLC.
Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy
PHASE2Randomized, placebo-controlled, multi-center, double-blind, proof of concep...
Location
FOMAT Medical Research - FOMAT - HyperCore - PPDS
Atacicept in Subjects With IgA Nephropathy
PHASE3A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)...
Status
Active Not Recruiting
Location
ORIGIN 3 Global Site Contact Information